165 related articles for article (PubMed ID: 37881785)
1. Methylation of
Li JW; Deng QM; Zhu JL; Min W; Hu XY; Yu Chen H; Luo Z; Lin LL; Wei XL; Zhang YQ; Lou KL; Gao YY; Zhang GJ; Bai JW
MedComm (2020); 2023 Dec; 4(6):e403. PubMed ID: 37881785
[TBL] [Abstract][Full Text] [Related]
2. The zinc-finger transcriptional factor Slug transcriptionally downregulates ERα by recruiting lysine-specific demethylase 1 in human breast cancer.
Bai JW; Chen MN; Wei XL; Li YC; Lin HY; Chen M; Li JW; Du CW; Man K; Zhang GJ
Oncogenesis; 2017 May; 6(5):e330. PubMed ID: 28481366
[TBL] [Abstract][Full Text] [Related]
3. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
4. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression.
Liu BW; Yu ZH; Chen AX; Chi JR; Ge J; Yu Y; Cao XC
J Exp Clin Cancer Res; 2019 Mar; 38(1):109. PubMed ID: 30823890
[TBL] [Abstract][Full Text] [Related]
7. DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations.
Gaudet MM; Campan M; Figueroa JD; Yang XR; Lissowska J; Peplonska B; Brinton LA; Rimm DL; Laird PW; Garcia-Closas M; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3036-43. PubMed ID: 19861523
[TBL] [Abstract][Full Text] [Related]
8. SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.
Atmaca A; Wirtz RW; Werner D; Steinmetz K; Claas S; Brueckl WM; Jäger E; Al-Batran SE
BMC Cancer; 2015 Apr; 15():300. PubMed ID: 25928859
[TBL] [Abstract][Full Text] [Related]
9. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
10. Sesamol Epigenetically Induces Estrogen Receptor α Re-expression by Upregulating miR-370-3p in Estrogen Receptor α-Negative Breast Cancer.
Ma X; Wang J; Hu G; Chen Y; Hu X; Zhu Y; Ding L; Ning S
J Agric Food Chem; 2021 Aug; 69(31):8737-8746. PubMed ID: 34325508
[TBL] [Abstract][Full Text] [Related]
11. The high methylation level of a novel 151-bp CpG island in the ESR1 gene promoter is associated with a poor breast cancer prognosis.
Quintas-Granados LI; Cortés H; Carmen MG; Leyva-Gómez G; Bustamante-Montes LP; Rodríguez-Morales M; Villegas-Vazquez EY; López-Reyes I; Alcaraz-Estrada SL; Sandoval-Basilio J; Soto-Reyes E; Sharifi-Rad J; Figueroa-González G; Reyes-Hernández OD
Cancer Cell Int; 2021 Dec; 21(1):649. PubMed ID: 34863151
[TBL] [Abstract][Full Text] [Related]
12. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DNA methylation and tumor suppression gene expression by miR-29b in leukemia patients and related mechanisms.
Chen YL; Zhang ZX; Shou LH; Di JY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):158-165. PubMed ID: 29364483
[TBL] [Abstract][Full Text] [Related]
15. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract][Full Text] [Related]
16. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
17. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
18. Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Dou CY; Fan YC; Cao CJ; Yang Y; Wang K
Dig Dis Sci; 2016 Apr; 61(4):1130-8. PubMed ID: 26660680
[TBL] [Abstract][Full Text] [Related]
19. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
20. Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma.
Zhang D; Jiang Z; Hu J; Sun X; Zheng Y; Shen Y
Front Immunol; 2023; 14():1117585. PubMed ID: 37251370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
